antigens, neoplasm

Single-cell sequencing on CD8⁺ TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer/testis antigen in non-small cell lung cancer
Hiroyasu Komuro, Shuichi Shinohara, Yasunori Fukushima, Ayako Demachi-Okamura, Daisuke Muraoka, Katsuhiro Masago, Takuya Matsui, Yusuke Sugita, Yusuke Takahashi, Reina Nishida, Chieko Takashima, Takashi Ohki, Yoshiki Shigematsu, Fumiaki Watanabe, Katsutoshi Adachi, Takashi Fukuyama, Hiroshi Hamana, Hiroyuki Kishi, Daiki Miura, Yuki Tanaka, Kousuke Onoue, Kazuhide Onoguchi, Yoshiko Yamashita, Richard Stratford, Trevor Clancy, Rui Yamaguchi, Hiroaki Kuroda, Kiyoshi Doi, Hisashi Iwata, Hirokazu Matsushita

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007180; DOI: 10.1136/jitc-2023-007180
Reactivation of low avidity tumor-specific CD8⁺ T cells associates with immunotherapeutic efficacy of anti-PD-1
Gessa Sugiyarto, Doreen Lau, Samuel Luke Hill, David Arcia-Anaya, Denise S M Boulanger, Eileen E Parkes, Edward James, Tim Elliott

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007114; DOI: 10.1136/jitc-2023-007114
Discovery of U2AF1 neoantigens in myeloid neoplasms
Melinda Ann Biernacki, Jessica Lok, Ralph Graeme Black, Kimberly A Foster, Carrie Cummings, Kyle B Woodward, Tim Monahan, Vivian G Oehler, Derek L Stirewalt, David Wu, Anthony Rongvaux, Hans Joachim Deeg, Marie Bleakley

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007490; DOI: 10.1136/jitc-2023-007490
Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis
Jason A Carter, Bharati Matta, Jenna Battaglia, Carter Somerville, Benjamin D Harris, Margaret LaPan, Gurinder S Atwal, Betsy J Barnes

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007935; DOI: 10.1136/jitc-2023-007935
Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery
Bing Zhang, Michal Bassani-Sternberg

Journal for ImmunoTherapy of Cancer Oct 2023, 11 (10) e007073; DOI: 10.1136/jitc-2023-007073
Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen
Pu Chen, Dongbo Chen, Dechao Bu, Jie Gao, Wanying Qin, Kangjian Deng, Liying Ren, Shaoping She, Wentao Xu, Yao Yang, Xingwang Xie, Weijia Liao, Hongsong Chen

Journal for ImmunoTherapy of Cancer Apr 2023, 11 (4) e006334; DOI: 10.1136/jitc-2022-006334
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model
Jayanth S Shankara Narayanan, Tomoko Hayashi, Suna Erdem, Sara McArdle, Herve Tiriac, Partha Ray, Minya Pu, Zbigniew Mikulski, Aaron Miller, Karen Messer, Dennis Carson, Stephen Schoenberger, Rebekah R White

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006133; DOI: 10.1136/jitc-2022-006133
Vaccinating against cancer: getting to prime time
Ryan Chang, James L Gulley, Lawrence Fong

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006628; DOI: 10.1136/jitc-2022-006628
Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al
Zinal S Chheda, Sabine Mueller, Bindu Hegde, Akane Yamamichi, Lisa H Butterfield, Hideho Okada

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e006617; DOI: 10.1136/jitc-2022-006617
H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2⁺ patients with diffuse midline glioma
Lena Immisch, George Papafotiou, Oliver Popp, Philipp Mertins, Thomas Blankenstein, Gerald Willimsky

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005535; DOI: 10.1136/jitc-2022-005535

Main menu

antigens, neoplasm

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

antigens, neoplasm

Pages